-
ABPI Website
-
Building a stronger reputation in the UK
-
Disclosure UK
- Methodological notes by company and year
Methodological notes by company and year
Methodological Notes by Year / Company
Every company disclosing data on Disclosure UK about healthcare professionals (HCPs), other relevant decision makers (ORDMs), and healthcare organisations (HCOs) has provided a Methodological Note which explains how they compiled their data. Please ensure that you consider these notes when you are exploring the data.
To download a full HCP, ORDM and HCO dataset for each year, please visit the Disclosure UK search.
|
A. MENARINI |
2024 2023 2022 |
ABBVIE |
2024 2023 2022 |
||
|
ACCORD |
2024 2023 2022 |
ADVANZ PHARMA | - - 2022 |
||
| ADVANZ UK & IRE | 2024 2023 2022 |
AGB |
2024 2023 - |
||
|
AGUETTANT |
2024 2023 2022 |
ALEXION |
2024 2023 2022 |
||
|
ALFASIGMA |
2024 - - |
ALIMERA SCIENCES |
2024 2023 2022 |
||
|
ALK-ABELLO |
2024 2023 2022 |
ALLERGAN |
- - 2022 |
||
|
ALLIANCE |
2024 2023 2022 |
ALMIRALL |
2024 2023 2022 |
||
|
ALNYLAM |
2024 2023 2022 |
ALTURIX |
2024 2023 2022 |
||
|
AMGEN |
2024 2023 2022 |
AMICUS THERAPUTICS |
2024 2023 2022 |
||
|
AMRYT |
- 2023 2022 |
ANGELINI |
2024 2023 2022 |
||
|
ASCENDIS |
2024 - - |
ASPEN |
2024 - - |
||
|
ASTELLAS |
2024 2023 2022 |
ASTRAZENECA |
2024 2023 2022 |
||
|
ATNAHS |
2024 2023 2022 |
BAUSCH & LOMB |
2024 2023 2022 |
||
|
BAXTER HEALTHCARE |
2024 2023 2022 |
BAYER |
2024 2023 2022 |
||
|
BESINS HEALTHCARE |
2024 2023 2022 |
BIAL |
2024 2023 2022 |
||
|
BIO PRODUCTS LABORATORY |
2024 2023 2022 |
BIOCRYST |
2024 2023 2022 |
||
|
BIOGEN IDEC |
2024 2023 2022 |
BIOMARIN EUROPE |
2024 2023 2022 |
||
|
BIOPROJET |
2024 2023 2022 |
BLUE EARTH DIAGNOSTICS |
2024 2023 2022 |
||
|
BOEHRINGER INGELHEIM |
2024 2023 2022 |
BRACCO |
2024 2023 2022 |
||
|
BRISTOL-MYERS SQUIBB |
2024 2023 2022 |
BRITANNIA |
2024 2023 2022 |
||
|
CAMURUS |
2024 2023 2022 |
CELLTRION HEALTHCARE |
2024 2023 2022 |
||
|
CHIESI |
2024 2023 2022 |
CHUGAI |
2024 2023 2022 |
||
|
CIPLA |
2024 2023 2022 |
CLINUVEL |
2024 2023 2022 |
||
|
CNX THERAPEUTICS |
2024 - 2022 |
CONSILIENT HEALTH |
2024 2023 2022 |
||
|
CROMA |
2024 2023 2022 |
CSL BEHRING |
2024 2023 2022 |
||
|
DAIICHI SANKYO |
2024 2023 2022 |
DERMAL LABORATORIES |
2024 2023 2022 |
||
|
DIURNAL |
2024 2023 2022 |
DR FALK |
2024 2023 2022 |
||
|
EISAI |
2024 2023 2022 |
ELI LILLY |
2024 2023 2022 |
||
|
ESTEVE |
2024 - - |
ETHYPHARM GROUP |
2024 2023 2022 |
||
|
EVER |
2024 2023 2022 |
EXELTIS |
2024 2023 2022 |
||
|
FERRING |
2024 2023 2022 |
FLYNN |
2024 2023 2022 |
||
|
FRESENIUS MEDICAL CARE |
2024 2023 2022 |
FRESENIUS KABI |
2024 2023 2022 |
||
|
GALAPAGOS BIOTECH |
- 2023 2022 |
GALEN |
2024 2023 2022 |
||
|
GE HEALTHCARE |
2024 2023 2022 |
GEDEON RICHTER |
2024 2023 2022 |
||
|
GILEAD |
2024 2023 2022 |
GLAXOSMITHKLINE |
2024 2023 2022 |
||
|
GRUNENTHAL |
2024 2023 2022 |
GUERBET |
2024 2023 2022 |
||
|
HRA |
2024 2023 2022 |
IBSA |
2024 2023 - |
||
IDORSIA |
2024 2023 2022 |
IMMEDICA |
2024 2023 2022 |
||
| INCYTE | 2024 - - |
INDIVIOR |
2024 2023 2022 |
||
|
INTERCEPT |
- - 2022 |
IPSEN |
2024 2023 2022 |
||
|
IQVIA IES |
2024 2023 2022 |
JANSSEN-CILAG (J&J CO) |
2024 - - |
||
|
JANSSEN-CILAG |
- 2023 2022 |
JAZZ |
2024 2023 2022 |
||
|
KORA |
2024 2023 2022 |
L.D. COLLINS |
2024 2023 2022 |
||
|
LEADIANT BIOSCIENCES |
2024 2023 2022 |
LEO |
2024 2023 2022 |
||
|
LUNDBECK |
2024 2023 2022 |
LUPIN |
2024 2023 2022 |
||
|
LUYE |
2024 - - |
MEDICE |
2024 2023 2022 |
||
|
MENARINI STEMLINE |
2024 2023 - |
MERCK SERONO |
2024 2023 2022 |
||
|
MERCK SHARP & DOHME |
2024 2023 2022 |
MERZ |
2024 2023 2022 |
||
|
MITSUBISHI TANABE |
2024 2023 2022 |
MODERNA | 2024 2023 2022 |
||
|
MUNDIBIOPHARMA |
- - 2022 |
MUNDIPHARMA MEDICAL |
2024 2023 2022 |
||
|
MUNDIPHARMA RESEARCH |
2024 2023 2022 |
NAPP |
2024 2023 2022 |
||
| NEON HEALTHCARE | 2024 2023 2022 |
NEURAXPHARM |
2024 2023 2022 |
||
|
NORGINE |
2024 2023 2022 |
NOVARTIS |
2024 2023 2022 |
||
|
NOVO NORDISK |
2024 2023 2022 |
OCTAPHARMA |
2024 2023 2022 |
||
|
ORGANON |
2024 2023 2022 |
ORION |
2024 2023 2022 |
||
|
ORPHALAN |
2024 2023 2022 |
OTSUKA |
2024 2023 2022 |
||
|
OUTLOOK |
2024 - - |
PACIRA BIOSCIENCES | 2024 2023 2022 |
||
|
PAION |
2024 2023 2022 |
PARI MEDICAL |
2024 2023 2022 |
||
|
PFIZER |
2024 2023 2022 |
PIRAMAL CRITICAL CARE |
2024 - - |
||
|
PHARMAMAR |
- 2023 2022 |
PHARMASURE |
- - 2022 |
||
|
PHARMA NORD |
2024 2023 - |
PIERRE FABRE |
2024 2023 2022 |
||
|
PROFILE |
- - 2022 |
PROVECA |
2024 2023 2022 |
||
|
PROVEPHARM |
2024 - - |
PTC THERAPEUTICS |
2024 2023 2022 |
||
RECKITT |
2024 2023 2022 |
RECORDATI UK | 2024 - - |
||
|
RECORDATI |
2024 2023 2022 |
RECORDATI RARE DISEASES |
2024 2023 2022 |
||
|
REGENERON |
2024 2023 2022 |
RHYTHM |
2024 2023 - |
||
|
ROCHE |
2024 2023 2022 |
ROSEMONT |
2024 2023 2022 |
||
|
SAMSUNG BIOEPIS |
2024 2023 - |
SANOFI AVENTIS |
2024 2023 2022 |
||
|
SANTEN |
2024 2023 2022 |
SANTHERA |
2024 - - |
||
|
SEQIRUS |
2024 2023 2022 |
SERVIER |
2024 2023 2022 |
||
|
SHIONOGI BV |
2024 2023 2022 |
SIFI |
2024 2023 2022 |
||
|
SOBI |
2024 2023 2022 |
STD PRODUCTS |
- 2023 - |
||
|
STIRLING ANGLIAN |
2024 2023 2022 |
SUN |
2024 2023 - |
||
|
SYNER-MED |
2024 2023 2022 |
SYRI |
- 2023 2022 |
||
|
TAKEDA |
2024 2023 2022 |
TEVA |
2024 2023 2022 |
||
|
THEA |
2024 2023 2022 |
THERAMEX |
2024 - - |
||
|
THERATECHNOLOGIES |
- - 2022 |
TILLOTTS |
2024 2023 2022 |
||
|
UCB |
2024 2023 2022 |
VALNEVA |
2024 2023 2022 |
||
|
VERITON |
2024 2023 2022 |
VIFOR GROUP |
2024 2023 2022 |
||
|
VISUFARMA |
2024 2023 - |
ZAMBON |
2024 2023 2022 |
Last modified: 28 October 2025
Last reviewed: 28 October 2025